CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions

CareDx, Inc. is dedicated to improving the lives of organ transplant patients through noninvasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx strives to stay at the forefront of organ transplant surveillance solutions.

CareDx in the News

CareDx to Present New Data on AlloMap and AlloSure at ISHLT
April 3, 2017
AlloSure Featured in Journal of Applied Laboratory Medicine
March 14, 2017
AlloSure Featured in Journal of the American Society of Nephrology
March 9, 2017
Press Release Archive
The journal article can be found here.

Information on CareDx

CareDx Company Update



Learn about AlloMap

AlloMap is a non-invasive blood test that helps physicians identify the risk of acute cellular rejection in heart transplant recipients.


Hear what doctors and patients say about AlloMap

Upcoming Events

Look for CareDx at the following 2017 conferences:

EFI conference
Mannheim, Germany
May 30 – June 2, 2017

ASHI conference
San Francisco, United States
September 11-15, 2017

HFSA conference
Dallas, United States
September 16-19, 2017